Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study

[1]  S. Chambers,et al.  Assessing the effectiveness of decision aids for decision making in prostate cancer testing: a systematic review , 2015, Psycho-oncology.

[2]  R. Eeles,et al.  The psychological impact of undergoing genetic‐risk profiling in men with a family history of prostate cancer , 2015, Psycho-oncology.

[3]  G. Mann,et al.  Improving subjective perception of personal cancer risk: systematic review and meta‐analysis of educational interventions for people with cancer or at high risk of cancer , 2014, Psycho-oncology.

[4]  A. Muacevic,et al.  Quality of life in the follow-up of uveal melanoma patients after CyberKnife treatment , 2013, Melanoma research.

[5]  S. Merajver,et al.  Individual and family characteristics associated with BRCA1/2 genetic testing in high‐risk families , 2013, Psycho-oncology.

[6]  K. Hood,et al.  A self‐help coping intervention can reduce anxiety and avoidant health behaviours whilst waiting for cancer genetic risk information: results of a phase III randomised trial , 2013, Psycho-oncology.

[7]  C. Seynaeve,et al.  Long‐term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile , 2013, Psycho-oncology.

[8]  N. Bornfeld,et al.  Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study , 2012, British Journal of Cancer.

[9]  E. Dagan,et al.  A follow‐up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processes , 2011, Psycho-oncology.

[10]  B. Damato,et al.  Reconciling the principle of patient autonomy with the practice of informed consent: decision‐making about prognostication in uveal melanoma , 2011, Health expectations : an international journal of public participation in health care and health policy.

[11]  S. Athar.  Principles of Biomedical Ethics , 2011, The Journal of IMA.

[12]  A. Stiggelbout,et al.  Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2‐result , 2012, Psycho-oncology.

[13]  A. Brédart,et al.  Qualité de vie et état psychologique de patients atteints d’un mélanome de la choroïde : étude longitudinale , 2011 .

[14]  A. Stanton,et al.  Reactions to and Desire for Prognostic Testing in Choroidal Melanoma Patients , 2009, Journal of Genetic Counseling.

[15]  B. Damato,et al.  Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research , 2009, Eye.

[16]  J. Gebert,et al.  Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members , 2008, Clinical genetics.

[17]  Judi Homewood,et al.  Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk , 2008, Cancer.

[18]  Jean L. Jenkins,et al.  Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study , 2008, Psycho-oncology.

[19]  E. Thiel,et al.  Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases , 2008, Eye.

[20]  D. Chung,et al.  Knowledge and Attitudes about Microsatellite Instability Testing among High-Risk Individuals Diagnosed with Colorectal Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[21]  Nancy Kraetschmer,et al.  Do people want to be autonomous patients? Preferred roles in treatment decision‐making in several patient populations , 2007, Health expectations : an international journal of public participation in health care and health policy.

[22]  N. Bornfeld,et al.  The impact of diagnosis and plaque radiotherapy treatment of malignant choroidal melanoma on patients' quality of life , 2006, Psycho-oncology.

[23]  B. Meiser,et al.  Psychological impact of genetic testing for cancer susceptibility: an update of the literature , 2005, Psycho-oncology.

[24]  P. Butow,et al.  Communicating prognosis in cancer care: a systematic review of the literature. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  M. Keller,et al.  Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. , 2005, Journal of psychosomatic research.

[26]  Y. Brandberg,et al.  The EORTC Ophthalmic Oncology Quality of Life Questionnaire Module (EORTC QLQ-OPT30). Development and Pre-Testing (Phase I-III) , 2004, Eye.

[27]  M. Zehetmayer,et al.  Influence of uveal melanoma therapy on patients' quality of life: a psychological study. , 2004, Acta ophthalmologica Scandinavica.

[28]  Jeannie V Pasacreta,et al.  Psychosocial Issues Associated with Genetic Testing for Breast and Ovarian Cancer Risk: An Integrative Review , 2003, Cancer investigation.

[29]  B. Meiser,et al.  What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. , 2002, Social science & medicine.

[30]  Y. Brandberg,et al.  Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: A one year follow-up study , 2000, Eye.

[31]  J. Holland,et al.  Rapid screening for psychologic distress in men with prostate carcinoma , 1998, Cancer.

[32]  N. Bornfeld,et al.  Prognostic implications of monosomy 3 in uveal melanoma , 1996, The Lancet.

[33]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[34]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[36]  A. Antonovsky.  The structure and properties of the sense of coherence scale. , 1993, Social science & medicine.

[37]  Meyer Williams,et al.  Psychological Study , 1982 .

[38]  N. Bornfeld,et al.  [Uveal melanoma: current insights into clinical relevance of genetic testing]. , 2013, Klinische Monatsblatter fur Augenheilkunde.

[39]  C. Bungener,et al.  [Quality of life and psychological state in patients with choroidal melanoma: longitudinal study]. , 2011, Bulletin du cancer.

[40]  J. Emery,et al.  Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis , 2005, Familial Cancer.